2018 American Transplant Congress Archives - Page 42 of 211

DAP12 and Its Triggering Co-Receptor TREM2 Play Key Roles in Regulation of Mouse and Human Liver DC Function and Control of Liver Ischemia-Reperfusion Injury

T. Nakao,¹ Y. Ono,¹ H. Dai,¹ A. Perez-Gutierrez,¹ G. Camirand,¹ H. Huang,¹ D. Geller,^1,2 A. Thomson.^1,3
Daptomycin Minimum Inhibitory Concentration (MIC) of Vancomycin Resistant Enterococcal (VRE) Blood Isolates Correlates with Allograft Failure in Orthotopic Liver Transplant (OLT) Recipients

R. Lee,¹ G. Haidar,² J. Lewis,³ S. Arif,⁴ J. Hand,⁵ E. Holaday,⁶ H. Clauss,⁶ J. Goldman,⁷ A. Nellore.¹
DCD Kidneys with Remuzzi Scores of 4-5 Can Be Accepted for Solitary Kidney Transplantation

X-.P. Yuan, C-.B. Chen, Y. Zheng, J. Zhou, C. Wang, X. He.
DCD Utilization in Cholestatic Liver Disease: Distinct Outcomes between PSC and PBC Recipients

J. Pasko, E. Maynard, E. Dewey, K. Roayaie, S. Orloff, D. Scott, W. Naugler, J. Ahn, C. Enestvedt.
De Nove Malignancies after Liver Transplantation: Single Center Experience in Korea

Y. Yoon,¹ J. Lee,¹ Y. You,² D. Kim.²
De Novo Belatacept in Clinical Vascularized Composite Allotransplantation

L. C. Cendales,¹ D. S. Ruch,² A. R. Cardones,³ G. Potter,⁴ J. Dooley,⁵ D. Dore,⁶ J. Orr,¹ G. Ruskin,⁶ M. Song,¹ D. Chen,⁷ A. Selim,⁷ A. D. Kirk.¹
De Novo Donor Specific Antibodies in Pediatric Kidney Transplant Recipients Are Highly Responsive to Therapy

V. Sigurjonsdottir, P. Grimm.
De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation

N. Garg, T. Ellis, R. Redfield, S. Parajuli, B. Astor, A. Djamali, D. Mandelbrot.
De Novo or Early Conversion to Everolimus and the Risk of Skin Cancers in Kidney Transplant Recipients: A Trial-Based Linkage Study

T. Ying,^1,2 G. Wong, W. Lim, G. Russ, H. Pilmore, J. Kanellis, D. Goodman, P. Trevillian, S. Campbell, M. Suranyi, M. Mathew, R. Faull, R. Masterson, R. Walker, P. O'Connell, S. Chadban.^1,2
De Novo Use of Extended Released Tacrolimus (Meltdose, Envasus^R)) after OLT – Does the Colonic Resorption Influences the Outcome?

T. Soliman, G. Györi, M. Hofmann, A. Salat, S. Rockenschaub, G. Berlakovich.
Death-Censored Graft Failure (DCGF) Post Kidney Transplant (KTx) is Usually the Result of Rapid Loss of Function after Periods of Stability

R. Gaston,¹ L. Hunsicker,² A. Fieberg,³ A. Matas,³ The DeKaf Consortium.
Deceased Donor Initiated Kidney Transplant Exchanges and the Forgotten Incompatible Directed Donor Recipients

E. Molmenti,¹ C. Molmenti,² E. Grodstein,¹ H. Rilo,¹ L. Teperman.¹
Deceased Donor Urinary Biomarker Signature and the Effectiveness of Peritransplant Lymphocyte Depletion on Early Renal Allograft Function

S. Bernd,² P. Heeger,¹ T-.P. Heather,³ I. Hall,⁷ M. Doshi,⁴ F. Weng,⁵ P. Reese,⁶ C. Parikh.³
Deceased Pediatric Donor Livers: How Current Policy Drives Allocation and Transplantation

E. Hsu,² J. Ge,¹ J. Bucuvalas,³ J. Lai.¹
Decision-Making, Informed Consent, and the Experiences of Recipients of Experimental HCV Positive-to-Negative Renal Transplants

S. Rasmussen, S. Seaman, D. Brown, N. Desai, M. Sulkowski, D. Segev, J. Sugarman, C. Durand.
Decline in Pancreas Transplantation Numbers is Accompanied with Lower Publication Rates

S. Benjamens,¹ C. Margreiter,² E. de Koning,³ H. Leuvenink,¹ R. Pol.¹
Declining Number of Pancreas after Kidney Transplants Despite Significant Improvement in Outcome

A. Gruessner,¹ M. Laftavi,² O. Pankewycz,² R. Gruessner.¹
Decreased Clinical Significance of Isoagglutinin Titer with the Current Desensitization Protocol in ABO-Incompatible Kidney Transplantation

C. Baek, H. Kim, W. Yang, D. Han, S-.K. Park.
Decreased Expression of Pro-Carcinogenic Genes Following Tacrolimus to Sirolimus Conversion in Liver Transplant Recipients

M. Bhat,¹ E. Pasini,¹ C. Baciu,¹ S. Kurian,² J. Levitsky.³
Decreased Long-Term Survival with Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients

I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.
Decreased Post Heart Transplant Survival with Epstein-Barr Virus Mismatch in the Current Era

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, S. Mersola, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Deep Vein Thrombosis in Heart Transplant Patients

G. Bhat, T. Setia, C. Nguyen, I. Balanlayos, A-.G. Roska, A. Andrade, W. Cotts, G. Macaluso, S. Pauwaa, M. Bresticker, A. Tatooles, P. Pappas.
Defective Innate Immune Response to Opportunistic Pathogens in Cytomegalovirus-Infected Monocytes

P. Sen, A. R. Wilkie, R. Fernandes, R. J. Lane, S. E. Hickman, T. K. Means, E. R. Rosenberg, D. M. Coen, J. A. Fishman, J. El Khoury.
Defining Response to Standard of Care Treatment in Kidney Recipients with Antibody-Mediated Rejection: Role of C1q-Binding Donor-Specific Anti-HLA Antibodies

Y. Bouatou, D. Viglietti, O. Aubert, A. Loupy, C. Lefaucheur.
Defining T Cell Subsets Involved in Rejection of Vascularized Composite Allografts

G. Furtmueller,¹ V. Malek,¹ B. Oh,¹ S. Reddy,¹ M. Iglesias,¹ G. Raimondi,¹ G. Brandacher, D. Cooney.
Dehydropeptidase-Iinhibitor Reduces Tacrolimus-Induced Kidney Injury by Anti-Oxidative and Anti-Apoptotic Effect

K. Luo,¹ S. Lim,¹ J. Il,¹ Y. Shin,¹ E. Ko,^1,2 B. Chung,^1,2 H. Hwang,^1,2 C. Yang.^1,2
Delayed Achievement of Therapeutic Tacrolimus Levels after Renal Transplantation is Not Associated with Increased Incidence of Early Acute Rejection: Single-Center Results

R. Marshall, J. Brandenberger, A. Cantafio, J. Halldorson, R. Bakthavatsalam, A. Dick, S. Rayhill, J. Reyes, J. Perkins.
Delayed Graft Function in Live Donor HLA-Incompatible Kidney Transplant Recipients: A Multicenter Study

J. Motter,¹ A. Massie,¹ J. Garonzik Wang,¹ K. Jackson,¹ X. Luo,¹ A. Muzaale,¹ B. Orandi,² D. Segev.¹
Delayed Graft Function in Simultaneous Liver Kidney Transplantation

S. Weeks,¹ X. Luo,¹ S. Ottmann,¹ A. Gurakar,² F. Naqvi,² B. Philosophe,¹ A. Cameron,¹ N. Desai,¹ D. Segev,¹ J. Garonzik Wang.¹
Delayed Recovery of Renal Function after Donor Nephrectomy

J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
Delivery of Culturally-Competent Transplant Care among Hmong Kidney Transplant Recipients: Outcomes from a Single Institution

M. Odegard,¹ O. Serrano,¹ K. Peterson,¹ S. Mongin,² D. Berglund,³ D. Vock,⁴ S. Chinnakotla,¹ T. Dunn,¹ E. Finger,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas.¹
Demand for Uterine Transplantation in the United States: Initial Recruitment Results of a Trial of Uterine Transplantation in the Northeast U.S.

P. Porrett,¹ N. Latif,² E. Wang,² L. Sortor,³ S. Levin,⁴ A. Shaked,¹ K. Olthoff,¹ C. Coutifaris,² D. Driscoll,² K. O'Neill.²
Demographic and Geographic Differences in the Proportion of Liver Disease Deaths Captured by the Transplant Waitlist in the United States, 2011 – 2015

K. Ross,¹ R. Lynch,² D. Goldberg,³ R. Patzer.^1,2
Dependency on CD4 T Cells, Foreign Protein, and CD22 for Generation of Antibody Response to Non-Self Blood Group A-Antigen in a Mouse Model

I. Adam, B. Motyka, K. Tao, L. West.
Depletion Resistant Effector Memory T Cells Mediate Thymoglobulin Refractory Allograft Rejection in Human Intestinal Transplant Recipients

O. Aguirre, B. Houlihan, A. Karabala, C. Cosentino, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein, A. Kroemer.
Depressive Symptoms, Medication Nonadherence, and Clinical Outcomes Following Lung Transplantation

M. C. Chu,¹ P. J. Smith,² G. L. Stonerock,² J. A. Blumenthal.²
Derivation and Prospective External Validation of Prediction Models for Acute Kidney Injury in Adult Liver Transplant Recipients

Q. Zhao,¹ Z. Guo,¹ M. Chen,¹ S. Ma,¹ J. Lin,⁴ C. Zhang,² M. Han,³ X. He.¹
Desensitization to Facilitate Matching in a Large, National Kidney Paired Exchange Clearinghouse

C. Holscher,¹ A. Thomas,¹ K. Jackson,¹ C. Haugen,¹ M. Ronin,² A. Waterman,^3,4 A. Massie,^1,5 J. Garonzik Wang,¹ D. Segev.^1,5
Designing Novel Selective Immunoproteasome Inhibitors Reveals a Critical Role of the Immunoproteasome in Protecting Antibody Secreting B Cells from Apoptosis

J. Assaker,¹ N. Murakami,¹ S. Eskandari,¹ M. Uehara,¹ C. Nathan,² H. Li,³ G. Lin,² J. Azzi.¹
Despite the Growing Impact of the American Opioid Epidemic on Organ Donation, a Small Percentage of Drug Intoxication Deaths Result in Organ Donation

L. Hickman,¹ J. Killian,¹ S. Windham.^1,2
Detection of Different Gene Expression Profiles in CD8⁺ T Cells from Chronic High EBV Load Carriers after Pediatric Heart and Liver Transplantation

M. Yamada,^1,2 C. Macedo,² X. Gu,² M. Michaels,^1,2 M. Green,^1,2 C. Nguyen,^1,2 U. Chandran,³ B. Feingold,^1,2 G. Mazariegos,^1,2 D. Metes.^1,2
Determinants of Delays and Reduced Rates of Waitlisting and Kidney Transplant among American Indians

M. Keddis, M. Ilyas, N. Zhang, H. Khamash, S. Leischow, A. Sharma, R. Heilman.
Determining the Relative Immunogenicity of HLA Mismatches with Calcineurin Inhibitor Immunosuppression: An Analysis of the BENEFIT and BENEFIT-EXT Renal Transplant Cohort

V. Jucaud,¹ M. Roberts,² H. Gebel,³ R. Bray,³ M. Everly.¹
Determining the Utility of Protocol Biopsies in Kidney Transplant Recipients

J. Patel,¹ K. Heshmati,² A. Rogers,¹ R. Wali,² J. Jonsson,² C. Liu,² E. Emery,² D. Collins,² S. Karzai,² J. Piper.²
Developing a Rationale for an Appropriate Immunosuppressive Regimen in Lung vs Kidney Transplant Recipients: Effects of Induction Therapy

P. Martin-Moreno,^1,2 H. Shin,^1,3 H. Goldberg,⁴ A. Chandraker.¹
Development and Validation of a Socioeconomic Kidney Transplant Derailers Index (KTDI)

J. Peipert,^1,2 J. Beaumont,² M. Robbins,³ A. Paiva,³ C. Anderson,¹ A. Waterman.^1,2
Development and Validation of FLF-Transplant Score to Predict Mortality of Status 1A Candidates

Z. Guo, B. Chen, Q. Zhao, E. Xin, Z. Zhang, L. Wang, X. He, G. Chen.
Development and Validation of Nomogram to Predict Primary Non Function in Liver Transplant Recipients Using Donation after Cardiac Death Donor Graft

Z. Guo, J. Zeng, Q. Zhao, B. Chen, Z. Zhang, L. Wang, X. He.
Development of a Classification of Immunosuppressant Medication Nonadherence Tool to Enable the Objective Measurement of Immunosuppressant Medication Nonadherence in Kidney Transplant Patients

D. Goodall, M. Willicombe, A. McLean, D. Taube.
Development of a Novel Assay System for Ex Vivo T-Cell Mediated Rejection Responses in Intestinal Grafts

S. Okano,^1,2 K. Abu-Elmagd,² D. Kish,¹ K. Keslar,¹ M. Fujiki,² G. Costa,² C. Miller,² W. Baldwin,¹ R. Fairchild,¹ K. Hashimoto.²
Development of a Predictive Model for Deceased Donor Organ Yield

W. Marrero Colon,¹ M. Lavieri,¹ S. Guikema,¹ D. Hutton,² N. Parikh.³
Development of a Screening Tool to Predict Chronic Kidney Disease Risk in Post-Nephrectomy Living Kidney Donors

J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
Development of an Expert Consensus Guideline for Skin Cancer Screening in Solid Organ Transplant Recipients

L. Crow,¹ S. Arron,¹ C. Chung,² A. Jambusaria-Pahlajani,³ S. Lowenstein,¹ On behalf of the Transplant Skin Cancer Network.
Development of an Individualized Online Shared Decision Making Tool for Kidney Transplant Candidates

A. Hart,^1,2,3 M. Bruin,¹ S. Chu,¹ M. Partin,¹ A. Matas,¹ C. John,¹ A. Israni.^1,2,3
Development of Denovo DSA after One Year Post Kidney Transplant and Clinical Outcomes in Patient on Steroid Free Immunosupression

A. Sharfuddin, M. Yaqub, D. Mishler, W. Goggins, T. Taber, O. Adebiyi.
Development of Optimal Simplified Equation for Estimation of Mycophenolic Acid Exposure Following Enteric-Coated Mycophenolate Sodium Administration in Chinese Renal Transplant Recipients

W. Peng, C. Tian, Z. Chen, W. Xue, G. Wang, Q. Ye, X. Zhang, M. Gu, M. Zhao, C. Wang, C. Huang, J. Yan, W. Zhang, C. Ding, Y. Fu, S. Ye, X. Hu, R. Tan, M. Li, R. Deng, Y. Ke, W. Wu, M. Fan, J. Chen.
Development of Post-Transplant DSA Following Immunosuppression Minimization/Withdrawal in Liver Transplant Recipients

V. Jucaud,¹ A. Shaked,² M. DesMarais,³ P. Sayre,³ M. Everly.¹
Diabetic Nephropathy after Kidney Transplantation in Patients with Pre-Transplantation Type II Diabetes May Occur Later and Be Less Common Than Previously Thought

A. Cimeno, J. Munley, S. Sultan, M. Weir, S. Bartlett, C. Drachenberg, A. Hararian, J. Bromberg, J. Scalea.
Diagnosis and Prevalence of Strongyloidiasis in Solid Organ Transplant Patients

H. Pritchard,¹ V. Hemmige,¹ R. Mejia,² A. Restrepo.¹
Diagnosis of Acute Renal Rejection Using Saliva Metabolome Analysis

H. Iwamoto,¹ M. Sugimoto,² O. Konnno,¹ Y. Kihara,¹ T. Yokoyama,¹ Y. Nakamura,¹ M. Sunamura,¹ T. Ueno.¹
Diagnosis of Antibody-Mediated Rejection after Kidney Transplantation by Blood Expression of Genes Involved in IFN Signaling

M. Matz,¹ Q. Zhang,¹ F. Heinrich,² C. Lorkowski,¹ K. Wu,³ P. Durek,² N. Lachmann,⁴ M-.F. Mashreghi,² K. Budde.¹
Diagnostic Accuracy of Non-Invasive Test of Hepatic Fibrosis in Liver Transplant Recipients

D. Galvez,¹ C. Bhati,¹ M. Siddiqui,² C. Schmoyer,² T. Arshad,² A. Sharma,¹ A. Cotterell,¹ K. Yadav,¹ T. Reichman,¹ M. Levy.¹
Diagnostic Performance of Blood Pressure Measurement Modality in Prospective Living Kidney Donors

S. Armanyous, M. Lioudis, G. Thomas, E. Poggio, J. Augustine.
Diagnostic Usefulness of Medullary C4d Staining in Renal Allografts

J. Von Visger,¹ C. Von Visger, A. Satoskar,² T. Nadasdy,² J. Hemminger,² S. Brodsky.²
Diagnostic Value and Confounding Factors of Urinary Biomarkers in the Non-Invasive Screening of Renal Allograft Inflammation

A. Vermorel,¹ A. Devresse,¹ C. Tinel,^1,2 V. Sauvaget,² L. Morin,² L. Amrouche,^1,2 M. Rabant,^2,3 D. Anglicheau.^1,2
Dialysis Modality, Inflammation, and Frailty in Kidney Transplant Candidates

P. Shrestha, H. Ying, M. McAdams DeMarco, D. Segev.
Differences in Liver Waitlist Mortality Due to Geographic Disparity in Organ Availability

A. Massie,¹ S. DiBrito,¹ J. Motter,¹ M. Henderson,¹ S. Zhou,¹ K. Jackson,¹ D. Segev,¹ S. Gentry.²
Differences in Pediatric and Adult Lost to Follow-Up Events for Heart, Kidney, and Liver Recipients

A. Robinson,¹ G. Mazariegos,² S. Bartosh,³ W. Mahle.⁴
Differences in Preservation Solution Formulas and Its Effects on Early Graft Function

J. Brooks, P. Wiederhold, K. Jiles, A. Chiodo Ortiz, M. Dewey, M. Bailey, N. Koizumi, E. Rady, J. Ortiz.
Differences in Rejection and Clinical Outcomes in Obese versus Non-Obese Renal Transplant Recipients Receiving Basiliximab Induction Immunosuppression

J. Benken,¹ C. Kane,² A. Lichvar,¹ E. Benedetti.¹
Different Expression Patterns of Exosomal miRNAs under Cyclosporin A and Rapamycin Treatment in Distinct Aggressiveness Colorectal Carcinomas

V. Tubita,¹ M. Ramírez-Bajo,¹ J. Lozano,² D. Moya-Rull,¹ J. Rovira,³ J. Campistol,^4,5,6 F. Diekmann,^1,4,5,6 I. Revuelta.^1,4,5,6
Differential Effects of Inhibiting Glycolysis on Human Treg Subsets

N. Tanimine, B. Priyadharshini, S. Germana, L. Turka.
Diffuse Optical Non-Invasive Organ Risk (DONOR) Indexing Using Diffuse Reflectance Spectroscopy for Pre-Transplant Evaluation

H. Borron,¹ D. Piao,² A. Hawxby,³ H. Wright,³ E. Rubin.⁴
Digital Health Education for the Pediatric Solid Organ Transplant Population

T. Nemeth,¹ J. Smith,² A. Pollack,² W. Swanson,³ E. Hsu.⁴
Digital-Enabled Refills and Medication Adherence among Transplant Recipients

S. Boghani, H. Kirkham, G. Pietradoni, N. Hira.
Direct Oral Anticoagulation Use in Kidney Transplant Recipients

S. Shaikh,¹ M. Samaniego,² J. Park.²
Direct-Acting Antiviral Therapy Immune-Mediated Graft Dysfunction in Liver Transplant Recipients with Hepatitis C

C. Chan,¹ E. Agudelo,² J. Haydek,³ M. Hoteit,⁴ M. Laurito,⁵ J. Norvell,³ T. Schiano,⁶ N. Terrault,² E. Verna,⁵ A. Yang,¹ J. Levitsky.¹
Discard and Post-Transplant Outcomes Associated with Organs Donated after Drug-Overdose Death

M. Bowring, C. Durand, L. Kucirka, A. Thomas, A. Massie, M. Sulkowski, A. Cameron, N. Desai, D. Segev.
Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection

J. Assaker,¹ A. Srivastava,¹ J. Hurley,² B. Al Doujailan,¹ S. Eskandari,¹ C. Coticchia,² M. Mohamed,¹ S. Bentink,² V. Tadigotla,² L. Riella,¹ A. Chandraker,¹ J. Skog,² J. Azzi.¹
Discriminative Accuracy of Physician Assessments of Kidney Transplant Candidate Function by Candidate Age, Sex, and Race

M. Harhay,¹ K. Ranganna,¹ L. Levin Mizrahi,¹ G. Xiao,¹ G. Malat,¹ D. Reich,¹ S. Guy,¹ P. Reese.²
Disparate Candidate Selection Practices and Substantial Use of Low KDPI Kidneys in Combined Heart-Kidney and Liver-Kidney Transplantation, 2012-2016

R. Steiner,¹ J. Halldorson.²
Disparate Risk Factors for Early and Late Death Impact Survival after Lung Transplant

C. Lehr, E. Blackstone, K. McCurry, L. Thuita, W. Tsuang, M. Valapour.
Disparities in Re-Transplantation among Pediatric Renal Transplant Recipients with Graft Failure

M. Basu,¹ R. Patzer,¹ R. George.^1,2
Disparity in Access to Kidney Allograft Offers among HIV+ Transplant Candidates

J. Cohen,¹ J. Locke,² B. Shelton,² R. Reed,² P. MacLennan,² D. Sawinski.¹
Distribution of Biopsy Proven Acute Rejection in a Large Pediatric Kidney Transplant Program: A Four Year Experience

C. Varnell, Jr.,¹ A. Carle,^2,3 D. Hooper.^1,2,3
DNA Methylation Age and Differential Patterns of DNA Methylation in Older Compared with Younger Kidney Transplant Recipients

J. Schaenman, X. Zhou, R. Guo, M. Rossetti, E. Liang, B. Abdalla, E. Lum, S. Bunnapradist, G. Danovitch, E. Reed, D. Elashoff.
Do High-Risk Categories Convey the Wrong Message to Waitlisted Patients – Is It Time to Reconsider the Absolute Risk of Graft Loss?

A. Zarinsefat, H. Braun, S. Syed, B. Orandi, G. Roll.
Do Protocol Biopsies in the Highly Sensitized Improve Renal Allograft Survival? A Single Center Evaluation of 2 Year Graft Function

S. Kuppachi, R. Kalil, M. Fraer, M. Sanders, M. Swee, Z. Stewart, C. Thomas.
Do Recent Heart Transplant Patients Need to Reside Close to the Transplanting Center? A Look at the Impact of Commuting Times on Clinical Outcomes

A. Velleca, E. Kransdorf, J. Patel, M. Kittleson, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Do Reconstruction Techniques for Two Renal Arteries Affect Long-Term Graft Survival after Living Donor Renal Transplantation?

S. Yamanaga, P. Stock, M. Tavkol, S-.M. Kang.
Do We Need to Worry about EBV DNAemia in the Late Post-Transplant Period?

M. Morton,¹ K. Daga,² P. Klapper,² M. Picton,¹ P. Vallely.²
Does Biliary Duct Reconstruction Technique Impact Liver Transplantation Outcomes?

R. Shahbazov,¹ M. Kessel,² K. Knapp,² F. Azari,² S. Tsutsui,³ A. Nickkholgh,¹ D. Maluf,¹ S. Pelletier.¹
Does DGF Result in Worse Outcomes in a Second Transplant?

B. Muth,¹ B. Astor,^1,2 J. Blazel,¹ J. Turk,¹ D. Mandelbrot,¹ A. Djamali,¹ S. Parajuli.¹
Does One Size Fit All? Implementing a Protocolized Ambulatory Tacrolimus Dosing Strategy in a Predominantly African American Renal Transplant Population

L. Gylten, C. Mardis, D. Taber, H. Meadows, C. Perez, Z. Elmaasarani, J. Fleming, N. Patel, P. Baliga, V. Rao, V. Rohan, N. Pilch.
Does Pre-Operative Angiographic Kidney Embolization Decrease Complications in Allograft Nephrectomy?

D. Harriman, V. Mujumdar, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, R. Stratta.
Does Prolonged Cold Ischemia Affect Outcomes in Donation after Cardiac Death Kidney Transplants?

D. Harriman, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.
Does the End Justify the Means? An Analysis of Outcomes in Recipients of Combined Kidney/Hematopoietic Stem Cell (HSC) Transplants and Comparison to Standard of Care (SOC) Patients

J. Leventhal,¹ A. Shetty,¹ L. Gallon,¹ K. Kurtenbach,¹ D. Stare,¹ S. Ildstad.²
Donation after Circulatory Death Donor Liver Transplantation without Ischemic Cholangiopathy: Is It Time to Expand DCD Liver Donor Pool?

C. Kubal,¹ P. Mihaylov,^1,2 B. Ekser,¹ A. Cabrales,¹ J. Fridell,¹ R. Mangus.¹
Donor TM6SF2 rs58542926 Genotype is a Risk Factor for Liver Graft Steatosis

I. Mikova,¹ M. Neroldova,² J. Hubacek,² D. Dlouha,² L. Kolesar,³ M. Jirsa,² E. Honsova,⁴ E. Sticova,⁴ V. Lanska,⁵ J. Spicak,¹ P. Trunecka.¹
Donor Acute Kidney Injury Does Not Affect Fibrosis on 1 Year Post-Transplant Kidney Biopsy

D. van der Windt, X. Chen, K. Lemon, C. Wu, N. Shah, R. Mehta, C. Puttarajappa, P. Sood, S. Hariharan, A. Ganoza, M. Wijkstrom, A. Humar, A. Tevar.
Donor and Procedural Variability in DCD Liver Transplant: Is It Time to Come to a Consensus?

L. Ruffolo, M. Balceniuk, R. Hernandez Alejandro.
Donor Bacteremia Does Not Impact Survival Following Heart Transplantation: A UNOS Registry Review

S. Hirji, A. Woolley, M. Pelletier, P. Shekar, F. Yazdchi, H. Mallidi, S. Singh.
Donor Bone Marrow CXCR4+ Foxp3+ Treg Cells Are Essential for Costimulation Blockade-Induced Long-Term Survival of Murine Limb Transplants

L. Wang,¹ Z. Wang,¹ R. Han,¹ G. Ge,¹ L. Levin,² M. Levine,² W. Hancock.^1,2
Donor Deficiency of RIP3 Phosphokinase Activity Shortens Cardiac Allograft Survival in the Setting of Costimulation Blockade

M. Zhu, K. Samy, L. Lin, J. Wang, L. Cendales, A. Kirk, A. Barbas, T. Brennan.
Donor Derived Renal Cell Carcinoma (RCC) Transmission Events 2008-2016: A Report of the OPTN Disease Transmission Advisory Committee (DTAC)

M. Pavlakis, M. Michaels, S. Tlusty, N. Turgeon, G. Vece, C. Wolfe, R. Wood, M. Nalesnik.
Donor Derived Transmissions in 2016-2017: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

C. Wolfe, S. Tlusty, G. Vece, R. Bag, G. Berry, J. Bucio, L. Danziger-Isakov, D. Florescu, D. Goldberg, C. Ho, R. La Hoz, K. Lilly, M. Malinis, A. Mehta, M. Nalesnik, R. Sawyer, L. Strasfeld, P. Wood, N. Theodoropoulos, M. Michaels.
Donor Hepatectomy Time in Donation after Circulatory Death Donors is an Independent Risk Factor for the Development of Biliary Strictures and Early Graft Loss after Transplantation

O. van Leeuwen,¹ M. van Reeven,² M. Fujiyoshi,¹ V. de Meijer,¹ R. de Kleine,¹ M. de Boer,¹ J. de Jonge,² J. Ijzermans,² W. Polak,² R. Porte.¹
Donor Hypothermia Outcomes in Living Kidney Transplantation

J. Buggs,¹ J. Wei,² E. Rogers,³ R. Liu,² V. Bowers.¹
Donor Liver Apoptosis is Associated with Early Allograft Dysfunction and Short-Time Graft Survival after Liver Transplantation

Z. Guo, Z. Zhu, Y. Tang, S. Huang, Z. Zhang, X. He, G. Chen.
Donor Plasma Mitochondrial DNA Predicts Post-Transplant Renal Allograft Outcomes

F. Han,¹ S. Wan,² N. Chen,² L. Zheng,³ N. Zhang,⁴ Q. Sun,¹ H. Li,¹ Z. Huang,¹ L. Hong,¹ Q. Sun.¹
Donor Reactive Eomesdermin^hiCD8⁺ T Cells Are Significantly Upregulated Early after Transplant in Kidney Transplant Patients without Rejection

A. Perez-Gutierrez,^1,2 D. Metes,¹ S. Hariharan,¹ A. Thomson,¹ M. Ezzelarab.¹
Donor Safety in Obese Patients: 1038 Consecutive Robotic Living Donor Nephrectomies

C. Di Bella,¹ M. Spaggiari,¹ K. Tulla,¹ P. Di Cocco,¹ J. Oberholzer,² I. Tzvetanov,¹ E. Benedetti.¹
Donor Specific Antibodies and Clinical Outcomes in Kidney Transplant Recipients

S. Wan,^1,2 S. Chadban,^1,2 K. Wyburn.^1,2
Donor Specific Antibodies Increase the Risk of Preeclampsia in Pregnant Kidney Transplant Recipients

M. Lubetzky, T. Muthukumar, J. Lee, J. Lee, C. Hartono, L. Mahla, D. Serur, D. Dadhania.
Donor T Cells Undermine the Graft-Protective Effect of DST Plus Anti-CD154

M. Iglesias, M. Chicco, W. Lee, G. Brandacher, G. Raimondi.
Donor Transmitted Nut Allergy Following Solid Organ Transplantation: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

R. Bag, S. Tlusty, G. Vece, T. Peterson, J. Schaenman, G. Berry, J. Bucio, L. Danziger-Isakov, D. Florescu, D. Goldberg, C. Ho, R. La Hoz, K. Lilly, M. Malinis, A. Mehta, M. Nalesnik, R. Sawyer, L. Strasfeld, P. Wood, N. Theodoropoulos, M. Michaels, C. Wolfe.
Donor-Derived Cell-Free DNA Identifies Antibody-Mediated Rejection with Graft Injury in DSA-Positive Kidney Transplant Recipients

S. Jordan,¹ S. Bunnapradist,² J. Bromberg,³ A. Langone,⁴ D. Hiller,⁵ J. Yee,⁵ J. Sninsky,⁵ R. Woodward,⁵ A. Matas.⁶
Donor-Derived Cell-Free DNA Outperforms Serum Creatinine Changes for Identifying Kidney Transplant Rejection

M. Weir,¹ D. Hiller,² J. Yee,² A. Matas.³
Donor-Derived Hepatitis B Virus (HBV) Infection: Analysis of the OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee (DTAC)

N. Theodoropoulos, S. Tlusty, G. Vece, G. Berry, J. Bucio, L. Danziger-Isakov, D. Florescu, D. Goldberg, C. Ho, R. La Hoz, K. Lilly, M. Malinis, A. Mehta, M. Nalesnik, R. Sawyer, L. Strasfeld, R. Wood, M. Michaels, C. Wolfe.
Donor-Specific Antibody Mediates Chronic, but Not Acute, Kidney Allograft Rejection in the Absence of Natural Killer Cells

T. Yagisawa, N. Dvorina, A. Valujskikh, W. Baldwin 3rd, R. Fairchild.
Donor-Specific B-Cell Tolerance after Successful ABO Blood Type Incompatible (ABOi) Living Donor Liver Transplantation (LDLT)

T-.J. Wu, Y-.C. Wang, C-.H. Cheng, T-.H. Wu, C-.F. Lee, H. Chou, K-.M. Chan, W-.C. Lee.
Donor-to-Recipient Weight Ratio is Significantly Associated with Hepatic Artery Thrombosis Following Pediatric Whole Liver Transplantation

S. Kim, G. Ramos-Gonzalez, Z. Labib, H. Kim, K. Vakili.
DonorNet and Biases in Decision-Making: An Organ Offer Simulation Study

D. Stewart,¹ J. Lindemans,² J. Schold,³ H. McGehee,¹ J. Kessler,⁴ C. Sullivan,⁴ M. Turner,² K. Mekeel,⁵ C. Berg,² R. Stratta,⁶ R. Formica,⁷ L. Ratner,⁸ D. Klassen,¹ B. Shepard.¹
Double Deficiency of Gelatinase-A and Gelatinase-B Does Not Protect against Hepatic Ischemia Reperfusion Injury

S. Duarte, P. Matian, S. Ma, R. Busuttil, A. Coito.
DSA Plus TCMR Leads to Poor Outcomes in Renal Allograft Recipients and This is Markedly Exacerbated by Non-Adherence

D. Chittka, A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.
DSA with TCMR Identifies High Risk Renal Transplant Recipients That Can Be Predicted by Proinflammatory Transitional B Cells

D. Chittka, A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.
DSA-Level Liver Availability and Liver Utilization

S. Zhou, M. Bowring, A. Massie, S. Gentry, D. Segev.
Dual Function of IRF1/IRF4 on Dendritic Cells in Mouse Liver Transplantation Model

G. Gu, T. Lu, N. Xu, Q. Xia.
Dual Inhibition of PI3K and mTORC2 Causes ERK Hyperactivation Induced by HLA-II Antibody in Human Endothelium

Y-.P. Jin, E. Reed.
Dunbar Syndrome in Liver Transplantation: Results of a Single Center Matched-Pair Analysis and a European Survey Study

D. Morales-Santana,¹ Z. Czigany,¹ J. Böcker,¹ A. Andert,¹ W. Schöning,¹ T. Ulmer,¹ J. Bednarsch,¹ I. Amygdalos,¹ F. Meister,¹ P. Isfort,³ M. Liebl,³ D. Kroy,² F. Tacke,² C. Trautwein,² U. Neumann,¹ G. Lurje.¹
Durable Donor Hematopoetic Stem Cell (HSC) Chimerism is Associated with Protection from Native Renal Disease Recurrence in Recipients of Combined HSC/Kidney Transplants

J. Leventhal,¹ L. Gallon,¹ J. Mathew,¹ J. Miller,¹ D. Stare,¹ S. Ildstad.²
Dynamics of CD25-Positive Myeloid Suppressor Cells in Solid Organ Transplanted Patients and Relationship with Rejection

A. Utrero-Rico,¹ R. Laguna-Goya,¹ F. Cano-Romero,¹ E. Gómez-Massa,² M. Fernandez-Ruiz,³ J. Aguado,³ E. Mancebo-Sierra,² M. Castro-Panete,² E. Paz-Artal.^1,2